Search
forResearch 10 of 1000+
- Efficacy and safety of the oral Janus kinase 3/tyrosine kinase expressed in hepatocellular carcinoma family kinase inhibitor ritlecitinib over 24 months: integrated analysis of the ALLEGRO phase IIb/III and long-term phase III clinical studies in alopecia areata
- Use of Finasteride in the Treatment of Men With Androgenetic Alopecia (Male Pattern Hair Loss)
- Letter to the Editor: androgenetic alopecia; drug safety and therapeutic strategies
- Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I–II feasibility study
- Bendamustine: an Old Drug in the New Era for Patients with Non-Hodgkin Lymphomas and Chronic Lymphocytic Leukemia
- Calcipotriene plus betamethasone dipropionate gel: a new combination therapy for scalp psoriasis
- Enhancing the Growth of Natural Eyelashes: The Mechanism of Bimatoprost-Induced Eyelash Growth
- First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: A phase II study
- Efficacy of Placental-Derived Mesenchymal Stem Cell Exosome Therapy in Treating Androgenetic Alopecia: A Clinical Trial Study
- PC-SPES Studies Promising, But Manufacturer Shuts Down
Community 10 of 420
- Any updates or news on Gt20029?
- So why did the first pyrilutamide phase III fail?
- TH07 by Triple Hair entering phase III trial
- Kintor Pharma Announces Completion of First Patient Enrollment in KX-826 Long-term Safety Phase III Trial for Treatment of AGA
- Breezula Phase III 12-Month Data Released by Cosmo Pharma
- Pyrilutamide phase III clinical trial results released
- What the Breezula Phase III results mean & realistic timeline
- Breezula 6 Month Topline Phase III Results Released
- Pelage to present PP405 Phase 2a clinical trial full results at an upcoming medical meeting - CMO Christina Weng says
- Kintor long term safety phase 3